Nikita Papers Limited (NSE:NIKITA)
India · Delayed Price · Currency is INR 83.45
+3.55 (4.44%)
At close: Jul 30, 2025
Verve Therapeutics Revenue
In the fiscal year ending March 31, 2025, Nikita Papers had annual revenue of 3.64B INR with 7.63% growth. Nikita Papers had revenue of 992.86M in the quarter ending March 31, 2025.
Revenue
3.64B
Revenue Growth
+7.63%
P/S Ratio
0.63
Revenue / Employee
18.13M
Employees
201
Market Cap
2.29B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 3.64B | 258.24M | 7.63% |
| Mar 31, 2024 | 3.39B | -597.31M | -15.00% |
| Mar 31, 2023 | 3.98B | 419.21M | 11.76% |
| Mar 31, 2022 | 3.56B | 2.38B | 201.91% |
| Mar 31, 2021 | 1.18B | 182.34M | 18.27% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,765.41B |
| HDFC Bank | 2,736.06B |
| Bharti Airtel | 1,729.85B |
| Tata Consultancy Services | 2,561.48B |
| ICICI Bank | 2,054.85B |
| State Bank of India | 3,429.39B |
| Infosys | 1,672.76B |
| Hindustan Unilever | 639.28B |